Cargando…

A Survey of Peptides with Effective Therapeutic Potential in Alzheimer’s Disease Rodent Models or in Human Clinical Studies

Alzheimer’s disease (AD) is a devastating neurodegenerative disorder and the most common cause of dementia. Today, only palliative therapies are available. The pathological hallmarks of AD are the presence of neurofibrillary tangles and amyloid plaques, mainly composed of the amyloid-β peptide (Aβ),...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, N, Funke, SA, Willbold, D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2012
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3426789/ https://www.ncbi.nlm.nih.gov/pubmed/22303971 http://dx.doi.org/10.2174/138955712800493942

Ejemplares similares

Peptides for Therapy and Diagnosis of Alzheimer’s Disease
por: Funke, Susanne Aileen, et al.
Publicado: (2012)

Tau Aggregation Inhibiting Peptides as Potential Therapeutics for Alzheimer Disease
por: Aillaud, Isabelle, et al.
Publicado: (2022)

Selection and Characterization of Tau Binding ᴅ-Enantiomeric Peptides with Potential for Therapy of Alzheimer Disease
por: Dammers, Christina, et al.
Publicado: (2016)

Peptides as Potential Therapeutics for Alzheimer’s Disease
por: Ribarič, Samo
Publicado: (2018)

Exogenous Bioactive Peptides Have a Potential Therapeutic Role in Delaying Aging in Rodent Models
por: Wang, Jianqiang, et al.
Publicado: (2022)

Rodent models of neuroinflammation for Alzheimer’s disease
por: Nazem, Amir, et al.
Publicado: (2015)

Mechanisms of Amyloid-β Peptide Clearance: Potential Therapeutic Targets for Alzheimer’s Disease
por: Yoon, Sang-Sun, et al.
Publicado: (2012)

Development of a Small D-Enantiomeric Alzheimer’s Amyloid-β Binding Peptide Ligand for Future In Vivo Imaging Applications
por: Funke, Susanne Aileen, et al.
Publicado: (2012)

The Role of HDL and HDL Mimetic Peptides as Potential Therapeutics for Alzheimer’s Disease
por: Chernick, Dustin, et al.
Publicado: (2020)

Rodent Models of Amyloid-Beta Feature of Alzheimer’s Disease: Development and Potential Treatment Implications
por: Poon, Chi Him, et al.
Publicado: (2020)

Stabilization of Monomeric Tau Protein by All D-Enantiomeric Peptide Ligands as Therapeutic Strategy for Alzheimer’s Disease and Other Tauopathies
por: Altendorf, Tim, et al.
Publicado: (2023)

Experimental Pharmacology in Transgenic Rodent Models of Alzheimer’s Disease
por: Cuello, A. Claudio, et al.
Publicado: (2019)

Revisiting rodent models: Octodon degus as Alzheimer’s disease model?
por: Steffen, Johannes, et al.
Publicado: (2016)

The D-amino acid peptide D3 reduces amyloid fibril boosted HIV-1 infectivity
por: Widera, Marek, et al.
Publicado: (2014)

Bridging the rodent to human translational gap: Marmosets as model systems for the study of Alzheimer's disease
por: Sukoff Rizzo, Stacey J., et al.
Publicado: (2023)

Therapeutic Potential of P110 Peptide: New Insights into Treatment of Alzheimer’s Disease
por: Srivastava, Ankita, et al.
Publicado: (2023)

Tailoring the Antibody Response to Aggregated Aß Using Novel Alzheimer-Vaccines
por: Mandler, Markus, et al.
Publicado: (2015)

Hippocampal Deficits in Amyloid-β-Related Rodent Models of Alzheimer’s Disease
por: Vyas, Yukti, et al.
Publicado: (2020)

mGluR-dependent plasticity in rodent models of Alzheimer’s disease
por: Valdivia, Gonzalo, et al.
Publicado: (2023)

In Vitro and In Vivo Efficacies of the Linear and the Cyclic Version of an All-d-Enantiomeric Peptide Developed for the Treatment of Alzheimer’s Disease
por: Schemmert, Sarah, et al.
Publicado: (2021)

IL-17 is a Potential Therapeutic Target in a Rodent Model of Otitis Media with Effusion
por: Zhang, Nanfeng, et al.
Publicado: (2022)

Characterization of a Single-Chain Variable Fragment Recognizing a Linear Epitope of Aβ: A Biotechnical Tool for Studies on Alzheimer’s Disease?
por: Dornieden, Silke, et al.
Publicado: (2013)

Therapeutic Potential of Human Stem Cell Implantation in Alzheimer’s Disease
por: Chan, Hau Jun, et al.
Publicado: (2021)

Use of rodents as models of human diseases
por: Vandamme, Thierry F.
Publicado: (2014)

Do We Need Anti-Prionic Compounds to Treat Alzheimer’s Disease?
por: Willbold, Dieter, et al.
Publicado: (2019)

Rodent Modeling of Alzheimer's Disease in Down Syndrome: In vivo and ex vivo Approaches
por: Farrell, Clíona, et al.
Publicado: (2022)

hiPSC-based models to decipher the contribution of human astrocytes to Alzheimer’s disease and potential therapeutics
por: TCW, Julia, et al.
Publicado: (2023)

Therapeutic potential of resveratrol in Alzheimer's disease
por: Vingtdeux, Valérie, et al.
Publicado: (2008)

Neuroinflammation as a Potential Therapeutic Target in Alzheimer’s Disease
por: Liu, Ping, et al.
Publicado: (2022)

Therapeutic Potential of Vitamin D and Curcumin in an In Vitro Model of Alzheimer Disease
por: Alamro, Abir Abdullah, et al.
Publicado: (2020)

Impact of alcohol-induced intestinal microbiota dysbiosis in a rodent model of Alzheimer’s disease
por: Frausto, Dulce M., et al.
Publicado: (2022)

Intrinsic, widefield optical imaging of hemodynamics in rodent models of Alzheimer’s disease and neurological injury
por: Crouzet, Christian, et al.
Publicado: (2023)

Rodent Models of Experimental Endometriosis: Identifying Mechanisms of Disease and Therapeutic Targets
por: Bruner-Tran, Kaylon L., et al.
Publicado: (2018)

Exploring the therapeutic efficacy of Chlorella pyrenoidosa peptides in ameliorating Alzheimer's disease
por: Wang, Shu-Mei, et al.
Publicado: (2023)

Terpenoids as Potential Anti-Alzheimer’s Disease Therapeutics
por: Yoo, Ki-Yeol, et al.
Publicado: (2012)

Detection of Soluble Amyloid-β Oligomers and Insoluble High-Molecular-Weight Particles in CSF: Development of Methods with Potential for Diagnosis and Therapy Monitoring of Alzheimer's Disease
por: Funke, Susanne Aileen
Publicado: (2011)

Impact and Therapeutic Potential of PPARs in Alzheimer's Disease
por: Heneka, Michael T, et al.
Publicado: (2011)

Therapeutic Potentials of Microalgae in the Treatment of Alzheimer’s Disease
por: Olasehinde, Tosin A., et al.
Publicado: (2017)

Alzheimer’s Disease and Its Potential Alternative Therapeutics
por: Kisby, Brent, et al.
Publicado: (2019)

Therapeutic Potential of Phytoconstituents in Management of Alzheimer's Disease
por: Singh, Anurag Kumar, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j7rcvs02p12ml4s0an1stkhqkk